Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

24. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.136-137

İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

21. Çapa Gastroenteroloji Günleri, İstanbul, Turkey, 31 March - 02 April 2022, pp.70

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Turkey, 23 - 27 March 2022, pp.38-39

Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 16 - 21 November 2021, pp.219

TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72 Sustainable Development identifier

Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68 identifier

Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68 identifier

Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi

34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Turkey, 18 - 22 October 2017, vol.26, no.3, pp.35

Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 October 2017, vol.66 Sustainable Development identifier

"Normal" Serum ALT/AST Level in Turkish Population

66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 13 - 17 November 2015, vol.62 identifier

Hasta ortada kalmasın Multidisipliner yaklaşım

"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Turkey, 11 - 13 March 2015

Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Joint International Congress of ILTS, ELITA and LICAGE, London, Canada, 4 - 07 June 2014, vol.20 identifier

The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience

55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, United States Of America, 3 - 06 May 2014, vol.146 identifier

Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58 identifier

The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013 identifier

Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58 Sustainable Development identifier

Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013 Sustainable Development identifier

Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013 Sustainable Development identifier

Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58 identifier

Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, United States Of America, 18 - 21 May 2013, vol.144 identifier

Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56 Sustainable Development identifier

Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56 identifier

Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions

Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.75, pp.136 identifier

ANTIVIRAL RESISTANCE IN NAIVE GENOTYPE D CHRONIC HEPATITIS B PATIENTS BY ULTRA-DEEP PYROSEQUENCING

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 4 - 08 November 2011, vol.54 Sustainable Development identifier

A NATIONWIDE PREVALENCE STUDY AND RISK FACTORS FOR HEPATITIS A, B, C AND D INFECTIONS IN TURKEY

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 29 October - 02 November 2010, vol.52 Sustainable Development identifier

CLEVUDINE TREATMENT OF CHRONIC DELTA HEPATITIS

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 29 October - 02 November 2010, vol.52 Sustainable Development identifier

CLONAL ANALYSIS OF THE QUASISPECIES OF ANTIVIRAL RESISTANT HBV GENOMES IN PATIENTS WITH ENTECAVIR RESISTANCE TREATED WITH RESCUE LAMIVUDINE-ADEFOVIR COMBINATION THERAPY

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 30 October - 03 November 2009, vol.50 identifier

A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132 identifier

Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)

57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 27 - 31 October 2006, vol.44 identifier

Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124 identifier

Metrics

Publication

186

Citation (WoS)

1855

H-Index (WoS)

18

Citation (Scopus)

4105

H-Index (Scopus)

22

Project

1

Open Access

6
UN Sustainable Development Goals